|
|
Office Locations:
|
Osler, Hoskin & Harcourt LLP 1000, rue De La Gauchetière Ouest, Bureau 2100
Montreal, H3A 2R7
Canada
Phone: 514-564-6474
| |
|
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Founded in 1979, Sanderling has supported over 90 biomedical companies from very early stages through commercial development. Sanderling focuses on new biomedical market opportunities including emerging technology in the following areas: Biotechnology, Therapeutics and pharmaceuticals, Drug delivery, Medical devices and instrumentation, Imaging and diagnostics, Medical Informatics, and Health care services.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
